#United States #New York #The Gross Law Firm #Investor Rights #Baxter International

Important Reminder for Baxter International Investors

Baxter International, Inc. (NYSE: BAX) shareholders should take note of a crucial announcement made by The Gross Law Firm. Investors who purchased shares within the designated class period, specifically from February 23, 2022, to July 30, 2025, are strongly encouraged to reach out to the firm before the deadline of December 15, 2025. This is essential for discussing potential legal rights and avenues for recovery in relation to recent allegations surrounding the company's product and business practices.

Allegations Against Baxter International

The basis of the allegations stems from claims that the Baxter’s Novum LVP product is marred by significant flaws, leading to severe malfunctions. These malfunctions raise serious safety concerns, exposing patients to the risk of injury or even death. Specifically, reports detail issues such as underinfusion, overinfusion, and failure to deliver fluids altogether. Furthermore, documents suggest that Baxter was aware of these critical defects, having been notified of numerous malfunctions, injuries, and fatalities associated with their devices, yet failed to adequately address these issues. The concern is exacerbated by the fact that the company’s measures to mitigate the risks—such as issuing customer alerts—have proven to be insufficient in resolving underlying design flaws.

Shareholders Encouraged to Register

Given these grave concerns, it’s apparent that shareholders should not procrastinate in registering for this class action lawsuit. Those who sign up will benefit from portfolio monitoring software provided by The Gross Law Firm, ensuring they stay informed about the case's progression. Importantly, registering does not oblige shareholders to seek lead plaintiff status, although this option remains available.

Why Contact The Gross Law Firm?

The Gross Law Firm is recognized nationally for its dedication to protecting investors from unethical business practices. They aim to support stakeholders who have suffered losses due to misleading statements and failures to disclose critical information by corporations. Their commitment lies in advocating for proper corporate governance and recovery for those adversely affected by potentially fraudulous actions.

Next Steps for Interested Shareholders

Potential plaintiffs can initiate their involvement by completing the loss submission form provided by the law firm. It is imperative for shareholders of Baxter International to act swiftly, as the deadline for those interested in lead plaintiff status is set for December 15, 2025. No financial commitment or cost is required to participate in the case, making it accessible for all eligible investors.

You can find more information and reach out to The Gross Law Firm directly here.

Conclusion

For those invested in Baxter International, now is the time to take action and ensure your rights are safeguarded. The allegations against the company raise significant concerns regarding product safety and corporate responsibility. Make sure to stay informed and proactive in protecting your investment and legal rights.